Evidence map›Paper›PMID 32286449›Full record

ArticleScientific reports2020

Detection and imaging of gadolinium accumulation in human bone tissue by micro- and submicro-XRF.

Anna Turyanskaya, Mirjam Rauwolf, Vanessa Pichler, Rolf Simon, Manfred Burghammer, Oliver J L Fox, Kawal Sawhney, Jochen G Hofstaetter, Andreas Roschger, Paul Roschger and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. PrNanomaterials (Basel, Switzerland) · 2025
    Review
  2. Ways to Measure Metals: From ICP-MS to XRF.Current environmental health reports · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Anna TuryanskayaTU Wien, Atominstitut, Stadionallee 2, Vienna, 1020, Austria. anna.turyanskaya@tuwien.ac.at.
Mirjam RauwolfTU Wien, Atominstitut, Stadionallee 2, Vienna, 1020, Austria.
Vanessa PichlerTU Wien, Atominstitut, Stadionallee 2, Vienna, 1020, Austria.
Rolf SimonKarlsruher Institute for Technology (KIT), ANKA Synchrotron Radiation Source, Hermann-von-Helmholtz-Platz 1, Eggenstein-Leopoldshafen, Karlsruhe, 76344, Germany.
Manfred BurghammerEuropean Synchrotron Radiation Facility, Avenue des Martyrs 71, Grenoble, 38043, France.
Oliver J L FoxDiamond Light Source Ltd, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, UK.
Kawal SawhneyDiamond Light Source Ltd, Harwell Science and Innovation Campus, Didcot, Oxfordshire, OX11 0DE, UK.
Jochen G HofstaetterLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department Hanusch Hospital, Heinrich-Collin-Strasse 30, Vienna, 1140, Austria.
Andreas RoschgerLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department Hanusch Hospital, Heinrich-Collin-Strasse 30, Vienna, 1140, Austria.
Paul RoschgerLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department Hanusch Hospital, Heinrich-Collin-Strasse 30, Vienna, 1140, Austria.
Peter WobrauschekTU Wien, Atominstitut, Stadionallee 2, Vienna, 1020, Austria.
Christina StreliTU Wien, Atominstitut, Stadionallee 2, Vienna, 1020, Austria.
TU Wien · ATDiamond Light Source · GBEuropean Synchrotron Radiation Facility · FRHanusch Hospital · ATKarlsruhe Institute of Technology · DELudwig Boltzmann Institute of Osteology · ATOrthopaedic Hospital Speising · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gadolinium-based contrast agents (GBCAs) are frequently used in patients undergoing magnetic resonance imaging. In GBCAs gadolinium (Gd) is present in a bound chelated form. Gadolinium is a rare-earth element, which is normally not present in human body. Though the blood elimination half-life of contrast agents is about 90 minutes, recent studies demonstrated that some tissues retain gadolinium, which might further pose a health threat due to toxic effects of free gadolinium. It is known that the bone tissue can serve as a gadolinium depot, but so far only bulk measurements were performed. Here we present a summary of experiments in which for the first time we mapped gadolinium in bone biopsy from a male patient with idiopathic osteoporosis (without indication of renal impairment), who received MRI 8 months prior to biopsy. In our studies performed by means of synchrotron radiation induced micro- and submicro-X-ray fluorescence spectroscopy (SR-XRF), gadolinium was detected in human cortical bone tissue. The distribution of gadolinium displays a specific accumulation pattern. Correlation of elemental maps obtained at ANKA synchrotron with qBEI images (quantitative backscattered electron imaging) allowed assignment of Gd structures to the histological bone structures. Follow-up beamtimes at ESRF and Diamond Light Source using submicro-SR-XRF allowed resolving thin Gd structures in cortical bone, as well as correlating them with calcium and zinc.

Indexed as

BiopsyContrast MediaCortical BoneGadoliniumHalf-LifeHumansMagnetic Resonance ImagingMaleMiddle AgedOsteoporosisSpectrometry, X-Ray EmissionSynchrotronsTime FactorsTissue DistributionContrast MediaGadolinium

Identifiers

PMID32286449
PMCPMC7156386
OpenAlexW3015195301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.